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Abstract 
Objective: To estimate full hepatitis B vaccination coverage (uptake of ≥3 doses of vaccine) 
among health-care workers (HCWs) in Africa. 
Methods: We systematically searched the PubMed®, Embase®, CINAHL and Psych-Info 
databases for studies published from January 2010 to October 2017 that reported full hepatitis 
B vaccination coverage among HCWs in Africa. A random effects meta-analysis was 
conducted to determine pooled estimates of full vaccination coverage. 
Results: Of the 331 articles identified, 35 studies from 15 African countries met the inclusion 
criteria and were included in the review. The estimated full hepatitis B vaccination coverage 
was 24.7% (95% CI: 17.3 – 32.0). Regional coverage was highest in northern Africa (62.1%, 
95% CI: 42.5 – 81.7) and lowest in central Africa (13.4%, 95% CI: 4.5 – 22.3). Doctors were 
more likely (OR: 2.6, 95% CI: 1.8 – 3.7) to be fully vaccinated than Nurses with estimated 
pooled estimates of 52.4% (95% CI: 31.1 – 73.8) and 26.3% (95% CI: 9.7 – 42.9), respectively. 
Also, HCWs with 10 or more years of experience were more likely to be vaccinated than those 
with less than 10 years of experience (OR: 2.2, 95% CI: 1.5 – 3.3). The common reasons 
identified for non-vaccination of HCWs were unavailability of vaccine 50.5% (95% CI: 26.5 – 
74.4), busy work schedule 37.5% (95% CI: 12.6 – 62.4) and cost of vaccination 18.4% (95% 
CI: 7.1 – 29.7). 
Conclusion: The evidence available suggests that many HCWs in Africa are at risk of 
Hepatitis B infection as only a quarter of them were fully vaccinated against Hepatitis B virus. 
This study highlights the need for all African governments to establish and implement 
hepatitis B vaccination policies for HCWs.  
Keywords: Hepatitis B; vaccination; occupational exposure; healthcare workers; Africa 
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Introduction 
Hepatitis B is a communicable disease caused by the hepatitis B virus (HBV) and transmitted 
through contact with blood or other body fluids of an infected person.[1, 2] The disease has 
become a ‘major public health challenge’ ranking as one of the leading global causes of 
mortality.[2] An estimated two billion people around the world are infected with HBV, and of 
these, approximately  257 million people suffer from chronic hepatitis B infection.[2]  The liver 
is primarily affected in HBV infection resulting in acute or chronic infection. Acute infection 
may result in a spectrum from asymptomatic to acute liver disease.[3, 4] About 5 -10% of adults 
with acute HBV infection progress to the chronic state.[3] Chronic infection can result in 
cirrhosis of the liver, liver cancer and liver failure. In 2015, hepatitis B resulted in about 887 
000 deaths, mostly associated with liver cirrhosis and liver cancer.[2]  
The African continent has one of the highest burden of Hepatitis B with 6.1% of the adult 
population living with the infection.[2] However, significant variation exist in HBV infection 
across African countries. Hepatitis B is hyper-endemic (> 8% of the general population are 
hepatitis B surface antigen chronic carriers) in some sub-Saharan African countries including 
Nigeria, Namibia, Gabon, Cameroon and Burkina Faso while other countries such as Kenya, 
Zambia, Sierra Leone and Senegal are of intermediate endemicity (2%-8%).[5]  On the other 
hand, countries in Northern Africa including Egypt, Tunisia, Algeria and Morocco had low 
endemicity levels (< 2%).[5] 
Hepatitis B virus is highly contagious. Individuals with chronic infection are usually the main 
reservoir for continued HBV transmission.[1] Health-care workers (HCWs) particularly have 
greater chances of hepatitis B infection due to  the risk of occupational  contact with blood and 
other body fluids of infected individuals.[6] This may occur following percutaneous injury (when 
a needle or other sharp object penetrates the skin), blood and body fluids coming in contact 
with the mucous membrane (eyes, nose and mouth) or non-intact skin exposure to blood and 
other body fluids. [7] Percutaneous injuries carry the greatest risk of HCW HBV infection and  
account for about 66,000 HBV infections annually.[8]  Every year, about a third of HCWs 
working in Africa are occupationally exposed to body fluids through percutaneous injuries,[7] 
which in the context of high prevalence of Hepatitis B in Africa puts HCWs at a high risk of 
HBV infection.  
Vaccination against HBV remains the most important strategy in the prevention and 
elimination of the infection.[2, 9]  A safe and effective vaccine has been available since 1982.2 
The World Health Organisation (WHO) and the Centre for Disease Control Advisory 
Committee on Immunization Practices recommend hepatitis B vaccination for HCWs who are 
at risk of occupational exposure to blood and other body fluids.[1, 2] Primary vaccination in 
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immunocompetent adults consists of a 3-dose series of Hepatitis B vaccine which when 
completed confers a protective antibody response in more than 90% of healthy  recipients 
aged ≤ 40 years. 1 The proportion of adults with protective antibody response decreases below 
90% in healthy adults over 40 years of age. From the age of 60 years, neutralising antibody 
protection reduces to 75% in vaccine recipients.1  
Given the consequences of HBV infection among HCWs and the potential for viral 
transmission to vulnerable patients (immuno-compromised or unimmunized), many developed 
countries have established policies and strategies to prevent the infection among their HCWs. 
In many countries across Europe, vaccination against Hepatitis B is a requirement for 
employment of HCWs at risk of occupational exposure to blood and other body fluids.[10] 
Hepatitis B vaccination strategies for infants and children have to a large extent been 
implemented with considerable success in many countries of Africa. However, policies 
regarding adult vaccination including those involving HCWs are yet to be implemented in many 
African countries.[11, 12]  
Several studies have investigated the level of hepatitis B vaccination coverage among HCWs 
in Africa and have reported full coverage as low as in 0.8% in Rwanda [13] and as high as 
72.0% in Libya [14]. However, no study to date has pooled the available data   on the current 
hepatitis B vaccination coverage among HCWs in the continent. Therefore, we performed a 
systematic review of observational studies to estimate the level of hepatitis B vaccination 
coverage among HCWs in Africa and describe the regional variation. Findings may inform 
policies for improved hepatitis B vaccination coverage among HCWs in the continent thereby 
contributing towards achieving the 2030 agenda for the elimination of the infection.[15] 
Methods 
Protocol registration and search strategy 
The research protocol was registered in the PROSPERO international prospective register of 
systematic reviews (CRD42017077808). We searched four databases (PubMed®, Embase®, 
CINAHL and PsychInfo) to identify studies reporting hepatitis B vaccination coverage among 
HCWs in Africa. These databases were searched for original research articles published from 
January 2010 to October 2017. The following search terms were combined using Boolean 
operators, hepatitis B, hepatitis B virus, vaccination, immunisation, health care workers, health 
workers, health personnel and Africa (Table 1). Additional articles including grey literature 
were identified through checking of the reference lists, Google and Google Scholar search. 
No language restrictions were applied to all the searches conducted. 
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Eligibility criteria 
Studies were included if they reported full hepatitis B vaccination coverage among HCWs in 
Africa. In this review, we considered HCWs to encompass all paid and unpaid individuals 
working in healthcare settings who have the potential for exposure to infectious materials 
including blood and body fluids. Therefore, we included studies that enrolled a variety of 
participants including doctors, nurses, laboratory technicians, auxiliary health care workers 
and students undertaking clinical training or experience in healthcare settings. 
Other inclusion and exclusion criteria relate to the design of the study. Studies were included 
if they were either of cohort or cross-sectional designs. Case reports, case series, case-control 
studies and qualitative studies were excluded. Conference articles and studies that contained 
fewer than 100 participants were similarly excluded.[7, 16] 
Two reviewers independently screened studies against the inclusion and exclusion criteria 
and any discrepancy was resolved by consensus. 
Quality assessment of included studies 
All included studies were assessed for quality on ten (10) criteria developed based on existing 
quality appraisal frameworks.[17, 18] These ten criteria assessed the internal and external 
validity of each included study with each criterion equally weighted (see Table 2). On the basis 
of the assessment, each article received a quality grade of low, moderate or high if they meet 
1-4, 5-7 and 8-10 criteria, respectively.  
Data extraction 
Two reviewers extracted data and any discrepancy was resolved by consensus. The following 
data were extracted from each included article and entered into a piloted form designed in 
Microsoft Excel (version 2016): author, year of publication, country where the study was 
conducted, sample size, response rate and hepatitis B vaccination coverage based on 
percentage of HCWs fully-vaccinated (completed three or more doses of hepatitis B vaccine) 
or partially-vaccinated (received 1 or 2 doses of hepatitis B vaccine).   Other data extracted 
were vaccination status by sex, years of working experience and profession. The reasons for 
non-vaccination were also extracted. 
Data analysis 
Statistical analyses were carried out using Stata version 14.2 (StataCorp. LP, College Station, 
United States of America). A random effects meta-analysis based on the DerSimonian and 
Laird approach,[19] was conducted to determine pooled estimates (with 95% confidence 
intervals) of hepatitis B vaccination coverage among HCWs. Sensitivity analyses were carried 
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out by excluding low-quality studies and the impact of excluding them was evaluated on the 
summary results. This was done to test the robustness of our findings.    
Inter study heterogeneity was assessed with Cochran’s Q (reported with a X2-value and p-
value) and Higgin’s I-squared (I2) statistic was employed to measure the percentage of total 
variation across studies that is due to heterogeneity.[20]  Sub-group and meta-regression 
analyses were conducted to explore the causes of heterogeneity. The covariates considered 
included geographical region, type of health facility, sampling procedure (random vs 
convenience sampling), sample size, proportion of doctors, proportion of nurses and study 
quality. Covariates were first tested individually and only those identified to be significant (p < 
0.10) were included in the multivariable model.  
Stratified analyses were conducted to determine the pooled prevalence of hepatitis B 
vaccination among doctors and nurses. In addition, Individual data for odd ratio were pooled 
together using a random effects model to present the odds of vaccination between groups. 
Results 
 Study selection 
The literature search identified 331 articles but only 35 were eligible for inclusion (Figure 1).   
Study characteristics  
Thirty-five (35) cross-sectional studies comprising 14802 HCWs from 15 African countries 
were included in the meta-analysis. West and East African countries contributed the largest 
numbers of studies evaluated, accounting for twelve studies (n=12) each (Table 3). The 
majority of the studies (n=25) were conducted solely among hospital staff. Following the 
methodological quality assessment, 5 (14.3%) studies were of high quality, 27 (77.1%) studies 
were of moderate quality and the remaining 3 (8.6%) were of low quality. None of the assessed 
studies was deemed representative of their national HCWs’ population. 
Full Hepatitis B vaccination coverage among HCWs  
The proportion of HCWs fully-vaccinated (received 3 or more doses of vaccines) against 
Hepatitis B varied widely with some studies reporting as low as 0.8% in Rwanda and as high 
as 72.0% in Libya (Figure 2). Consequently, national estimate was highest in Libya with a 
pooled vaccination coverage of 62.1% (see Table 4). The overall pooled full hepatitis B 
vaccination coverage among HCWs in Africa was 24.7% (95% CI: 17.3 – 32.0). The pooled 
full vaccination coverage following sensitivity analysis (exclusion of low-quality studies) was 
23.7% (95% CI: 16.1 – 31.3). This figure was comparable to the overall pooled estimate.  
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Subgroup analyses revealed a marked variation in regional vaccination coverage among 
HCWs in Africa (Table 5). The North African region had the highest regional coverage of fully 
vaccinated HCWs (62.1%, 95% CI: 42.5 – 81.7). Regional coverage was lower in Central 
(13.4%, 95% CI: 4.5 – 22.3) and East Africa (15.1%, 95% CI: 9.4 – 20.8).  The estimated full 
hepatitis B vaccination coverage among medical doctors and nurses were 52. 4% (95% CI: 
31.1 – 73.8) and 26.3% (95% CI: 9.7 – 42.9), respectively. Our analysis shows that medical 
doctors were more likely to be vaccinated than nurses with a pooled odds ratio (OR) of 2.6 
(95% CI: 1.8 – 3.7). The estimated full vaccination coverage among male and female HCWs 
were 24.2% (95% CI: 9.8 – 38.6) and 23.35% (95% CI: 10.4 – 36.2), respectively. There was 
no significant difference in the odds of vaccination between male and female HCWs (OR: 0.9, 
95%CI: 0.6 – 1.2). A statistically significant difference was demonstrated in the odds of 
vaccination in HCWs with 10 or more years of work experience versus those with less than 10 
years (OR: 2.2, 95% CI: 1.5 – 3.3). Three studies, Abdela et al.[21]  (conducted in Ethiopia), 
Noubiap et al.[22] (conducted in Cameroon) and Atiba et al.[23] (conducted in Nigeria) reported 
full vaccination coverage among clinical students, the figures were 2.0% , 18.0%  and 39.2% 
, respectively.  
Overall, substantial heterogeneities were observed among the studies for the estimated full 
vaccination coverage among HCWs (X2 = 9310.0, p < 0.000, I2= 99.6%). The sources of the 
variation were investigated using meta-regression, two covariates had p values below 0.10 in 
the bivariate analyses:  geographical region (p = 0.0085) and type of health-care facility 
(p=0.0770). These covariates explained 30.6% of the between-study variation in the estimated 
full vaccination coverage of HCWs in Africa.  
Partial hepatitis B vaccination  
Thirty studies reported disaggregated data on the proportion of HCWs with partial vaccination 
(1 or 2 doses of vaccines) against Hepatitis B. The partial vaccination coverage ranged from 
2.4% in Sudan [24] to 48.0% in South Africa [25]. The pooled estimate for partial vaccination 
coverage in Africa was 17.8% (95% CI: 13.7 – 21.8) (Figure 3). The regional coverage of 
partial vaccination does not mimic the pattern for full vaccination coverage. Partial vaccination 
coverage was highest in Southern Africa (34.0%, 95% CI: 21.1 – 46.9) and lowest in East 
Africa (7.6%, 95% CI: 4.7 – 10.5). The estimates for West, Central and North Africa were 
26.9% (95% CI: 21.4 – 32.5), 17.8% (95% CI: 9.9 – 25.8) and 17.6% (95% CI: 10.6 – 24.7), 
respectively. We found a large proportion of partially vaccinated doctors and nurses in studies 
conducted in Nigeria 42.6% [26]  and Burkina Faso 38.2%, respectively [27].  
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Reasons for non-vaccination 
Ten studies explored reasons for non-vaccination among HCWs who were not vaccinated. 
The most commonly reported reasons from these studies were: unavailability of vaccine 
50.5% (95% CI: 26.5 – 74.4), busy work schedule 37.5% (95% CI: 12.6 – 62.4) and cost of 
vaccination 18.4% (95% CI: 7.1 – 29.7) (Figure 4). Other reasons cited included Hepatitis B 
vaccination was not considered necessary/important 6.4% (95% CI: 1.7 – 11.0) and vaccine 
safety concerns 2.2% (95% CI: 1.0 – 3.5).  
Discussion 
This study presents a continent-wide estimate of hepatitis B vaccination coverage among 
HCWs in Africa. The results indicate that many HCWs in Africa are at risk of Hepatitis B 
infection as only a quarter are estimated to be fully vaccinated against the disease. Our 
estimate of full hepatitis B vaccination coverage (24.7%) among HCWs in Africa was not far 
from the 2003 WHO estimate of 18.0%.[8] This indicates little progress over a decade to 
increase hepatitis B vaccination coverage in Africa. The high prevalence of HBV infection 
across the continent and limited HBV vaccination coverage demonstrated in our study 
indicates a major shortfall in the drive to eliminate HBV infection.  
We found marked variation in the level of hepatitis B vaccination coverage across regions and 
countries of Africa, with lower vaccination coverage in Sub-Saharan African countries where 
there is intermediate to high hepatitis B endemicity. The reason for this variation is not entirely 
clear but it could be a reflection of national or local policies and strategies regarding hepatitis 
B vaccination of HCWs. For instance, in Libya where the vaccination coverage was highest, a 
free hepatitis B vaccination programme has been implemented in all the sites in which the 
studies were conducted.[14, 28] This free availability of vaccines could be responsible for the 
high coverage seen in Libya. In addition, the economic and political situations across African 
countries may explain the variation in vaccination coverage since these factors have been 
reported to impact on vaccine availability.[29] African countries with better economies such as 
Libya, Botswana and Nigeria had higher full vaccination coverage than those with worse 
economies such as Uganda, Rwanda and Democratic Republic of the Congo. Some studies 
conducted in certain hyper-endemic countries including Niger and Cameroon found that more 
than 90% of the surveyed HCWs have been exposed to HBV and have acquired natural 
immunity.[30, 31]  This reason may account for the low vaccination coverage in these hyper-
endemic countries.  
 Overall, about 18% of HCWs in Africa had partial vaccination. These HCWs may be in the 
process of achieving full vaccination. Partial vaccination coverage were more common in 
Southern and Western African countries. This may represent a renewed effort to scale-up 
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vaccination given the high endemicity of blood-borne infections in these regions, and the 
concerns about health workers’ protection following the significant loss of HCWs to 
occupationally acquired infections including tuberculosis and Ebola virus in the last decade.[32, 
33] On the other hand, partial vaccination may reflect difficulties with access to Hepatitis B 
vaccine or a lack of understanding that a full course provides longer lasting protection.  These 
areas can be targeted by national governments when prioritizing strategies to increase 
vaccination coverage among HCWs in Africa.  
This review found that medical doctors were more likely to be vaccinated than nurses (OR: 
2.6, 95% CI: 1.8 – 3.7). Many studies conducted in Africa have attributed greater knowledge 
of HBV infection to doctors in comparison to other professional groups. [34, 35] The high 
vaccination coverage seen among doctors in our review possibly reflects their greater 
awareness on the risk of Hepatitis B infection and the importance of its prevention. We also 
found that HCWs with 10 or more years of employment were more likely to be vaccinated  
when compared to those with less than 10 years of practice (OR: 2.2, 95% CI: 1.5 – 3.3). This 
is unsurprising given that HCWs with longer duration of employment have probably 
experienced more frequent incidents of occupational exposure to blood and other body fluids 
in their career. This increase in the number of incidents of occupational exposure to blood and 
other body fluids is likely to have facilitated actions toward the prevention of blood-borne 
infections including vaccination against HBV. Furthermore, it is likely that HCWs with a few 
years of employment have less appreciation of the occupational risk of Hepatitis B infection or 
might not have had the opportunity for vaccination earlier in their career because of the 
irregularity in the availability of vaccines in many African healthcare settings.   
Given that a safe and effective vaccine against hepatitis B virus exists, we strongly 
recommend a mandatory HCW vaccination policy for Africa tied to employment requirements. 
In France, hepatitis B vaccination is mandatory for students going into clinical training.[36] This 
practice has helped to increase vaccination coverage among clinical students in France. [36] 
Targeting matriculating students entering into health-care professional training programmes 
or professional certification in Africa could increase vaccination coverage among future health-
care professionals and help in protecting them during clinical training and their future medical 
careers. 
Several reasons for non-vaccination of HCWs including unavailability of vaccines and cost of 
vaccination were identified in this review. Many African countries have successfully 
implemented universal hepatitis B vaccination programmes for new-born babies improving 
vaccination coverage among infants.[12] HCW vaccination programs could be delivered 
alongside infant programs or modelled after them.  Limited availability of vaccines which is the 
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major constraint to uptake will require active government financial investment for procurement, 
storage and distribution of vaccines to frontline HCWs. Countries that have significant 
challenges in rolling out full Hepatitis B immunization coverage for HCWs may depend on 
technical support and resources from   organizations such as the World Health Organisation, 
GAVI and other international health organizations. 
Universal vaccination of HCWs (without prior testing) may only be a cost-effective strategy in 
countries with low or intermediate endemicity and not hyper-endemic countries such as 
Cameroon and Niger where a large proportion of HCWs have already been exposed to HBV 
and have acquired natural immunity. While natural immunity is conferred in a large number of 
HCWs in hyper-endemic countries, progressive disease can occur. Therefore, the priority in 
these countries should be the screening of HCWs for hepatitis B surface antigen and hepatitis 
B core antibody.[11] Such screening would help identify HCWs requiring vaccination and those 
with chronic infection who may benefit from antiviral treatment.  
This study is not without limitations. First, the reviewed studies were based on self-reported 
data which may be prone to recall and social desirability biases. Second, our review included 
single or limited reports from some countries and many of the included reports were regional 
studies which were not nationally representative of the countries in which they were 
conducted. This lack of national representativeness could potentially impact on the 
generalisability of our findings. Third, our findings are likely to be under-estimates of hepatitis 
B vaccination coverage given that many papers lacking disaggregated data on full and partial 
vaccination coverage were excluded. Although partial vaccination is not encouraged, many 
immunocompetent adults can be protected with two doses of hepatitis B vaccine.[1]  Finally, 
direct comparisons of our findings with other world regions with similar HBV infection burden 
such as the Western Pacific Region, is not possible given the absence of regional-wide 
systematic reviews and meta-analysis in this area. 
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Tables and figures 
Table 1: Search strategy 
# Searches 
1 (Hepatitis B or HBV or Hep B or Hepatitis B Virus or Hepatitis B Antigen or 
Hepatitis B Antibodies or Anti-HBsAg or viral hepatitis or hepatitis).af. 
2 (Vaccine* or immunisation or vaccinat* or immuni* or Viral Hepatitis Vaccines or 
Viral Hepatitis  Vaccines or Hepatitis B Vaccines or Immunotherapy).af 
3 (Health care worker* or Nurse* or Midwive* or Physician* or Surgeon* or Doctor* 
or Health personnel or Health worker* or Dentist* or Health staff or Medical 
personnel or Health personnel or Health officer*).af. 
4 (Africa or Nigeria or Senegal or Morocco or South Africa or Ethiopia or Kenya or 
Mauritius or Mauritania or Tanzania or Congo or Algeria or Tunisia or Libya or 
Ghana or Madagascar or Gabon or Cameroon or Mali or Zimbabwe or Sudan or 
Uganda or Somalia or Namibia or Angola or Mozambique or Rwanda or Eritrea 
or Burkina Faso or Gambia or Zambia or Botswana or Guinea or Djibouti or 
Niger or Malawi or Egypt or Togo or Liberia or Benin or Sierra Leone or 
Swaziland or Côte d’Ivoire or Chad or Central African Republic or Seychelles or 
Sao Tome and Principe or Cape Verde or Comoros or Burundi or Lesotho).af. 
5 1 and 2 and 3 and 4 
6 limit 5 to yr="2010 -Current" 
 
 
Table 2: Criteria used for the methodological quality assessment 
Criteria used for the methodological quality assessment 
Internal validity 
Description of methods 
1. Are important population characteristics specified? 
2. Is the study period specified? 
3. Is there a clear definition of hepatitis B vaccination status? 
4. Is the method of data collection properly described? 
Measurement instrument 
5. Is the measurement instrument validated? 
Reported prevalence 
6. Were prevalence data reported for those with partial and complete vaccination? 
7. Were prevalence data reported by demographic category? 
External validity 
8. Is the response rate >70%, or is the information on non-responders sufficient to 
make inference on the representativeness of the study population? 
9. Is the included population representative of the target/subnational population? 
10. Is the included population representative of the national population? 
All points were equally weighted 
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Figure 1: Flow diagram of article selection process 
 
35 studies included in 
quantitative synthesis (meta-
analysis)  
327 records identified through database 
searching (PubMed 114, EMBASE 189 & 
CINAHL 18 & PsychInfo 6) 
4 additional records identified through other 
sources  
 
239 records after duplicates removed  
239 records screened  
 
173 records excluded (records 
included reviews, opinion papers 
and primary research lacking 
vaccination coverage data)  
66 full-text articles assessed for 
eligibility  
 
31 full-text articles excluded 
Sample size less than 100 
(n=11) 
Conference abstract (n=6) 
No disaggregated data on fully-
vaccinated HCWs (n=9) 
No relevant data (n=5) 
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Table 3: Characteristics of included studies 
Study 
authors 
Study 
year 
Study participants and settinga % of HCWs 
with full 
vaccination 
% Full vaccination 
coverage by 
demographic category  
Quality 
grading 
Abdela et 
al.[21]  
2016 246 clinical students of the College of Medicine and Health 
Sciences, University of Gondar, Northwest Ethiopia 
2.0 ND Moderate 
Abebaw et 
al.[37]  
2017 410 HCWs in health facilities across Shashemene Zonal 
Town, Oromia Region, Ethiopia 
12.9 Nurse: 15.3,  Male: 8.5, 
Female: 15.9 
High 
Abeje and 
Azage [38]  
2015 374 HCWs in health facilities across Bahir Dar city 
administration. Bahir Dar town 
5.4 ND Moderate 
Abiola et al.[26]  2016 134 HCWs including doctors and nurses in a hospital in Lagos 
State, Nigeria 
48.5 Doctors: 40.4, Nurses: 
52.9, Male: 45.9, 
Female: 49.5 
High 
Adekanle et 
al.[35]  
2015 382 HCWs including doctors, nurses and laboratory 
technologists in Obafemi Awolowo University Teaching 
Hospitals, Ile-Ife, Nigeria 
65 Doctors: 85.0, Nurses: 
52  
Moderate 
Alese et al.[39] 2016 187 HCWs including doctors, nurses, health attendants and 
porters in Ekiti State University Teaching Hospital, Ado- Ekiti.  
16 ND Low 
Amira and 
Awobusuyi [40] 
2014 102 HCWs including doctors, nurses, dialysis technicians and 
auxiliary health staff in four (two government and two private) 
dialysis units in Lagos, Nigeria. 
32.4 ND Moderate 
Amsalu et 
al.[41]  
2016 152 medical waste handlers in three government hospitals, 
southern Ethiopia 
4.6 ND Moderate 
Atiba et al.[23] 2014 594 clinical students of Obafemi Awolowo University 39.2 ND Moderate 
Ayalew and 
Horsa [42] 
2017 286 HCWs including doctors and nurses in Gondar 
University Hospital, Gondar, Ethiopia. 
28.7 ND High 
Burnett et 
al.[25] 
2011 723 HCWs including nursing students from three colleges in 
Gauteng, doctors and nurses working in private and public 
hospitals/clinics in Tshwane Metro and Ekurhuleni Metro of 
Gauteng.  
19.9 ND Moderate 
Elzouki et 
al.[28] 
2014 601 HCWs including doctors, nurses, lab technicians, nurse-
aids and cleaners in five main hospitals in eastern Libya. 
52 ND Moderate 
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Kassa et al.[43] 2016 1624 HCWs including doctors, nurses and laboratory 
technicians in 3 public hospitals in Botswana: a referral 
hospital and 2 district hospitals. 
47 ND Moderate 
Kateera et 
al.[13] 
2015 378 doctors, nurses and laboratory and support staff in the 
University Teaching Hospital of Butare, Huye District, 
Southern Province, Rwanda 
0.8 ND Moderate 
Kesieme et 
al.[44]  
2011 228 operating room personnel in four university teaching 
hospitals in Nigeria 
26.8 ND Moderate 
Machiya et 
al.[45] 
2015 200 HCWs including doctors, nurses and laboratory staff in 
Princess Marina Hospital 
31.0 
 
Moderate 
Mueller et 
al.[46] 
2015 598 HCWs including doctors, nurses, lab staff and cleaners in 
Bugando Medical Centre in Mwanza, Tanzania 
48.8 ND Moderate 
Noubiap et 
al.[22] 
2013 111 clinical medical students of the Faculty of Medicine and 
Biomedical Sciences of the University of Yaoundé 
18 ND Moderate 
Noah et al.[47]  2013 282 HCWs including doctors and nurses of Yaoundé Central 
Hospital  
4.6 ND Moderate 
Nouetchognou 
et al.[48] 
2016 150 HCWs including doctors, nurses, nursing assistants and 
laboratory technicians in Yaoundé University Teaching 
Hospital 
36.7 ND Moderate 
Ogoina et 
al.[49] 
2014 290 HCWs including doctors, nurses and laboratory staff in 
two tertiary hospitals in North-central and South-south Nigeria 
36.2 ND Moderate 
Okwara et 
al.[50] 
2012 169 HCWs including doctors, nurses, lab staff and cleaners in 
a tertiary hospital 
29.8 ND Low 
Olatosi and 
Anaegbu[51] 
2016 274 HCWs including doctors, nurses, anaesthetic technicians 
and porters in five hospitals in Lagos, Nigeria 
58 Doctors: 69.8, Nurses: 
26.4 
Low 
Quedraogo et 
al.[27] 
2013 452 HCWs including doctors, nurses, nursing assistants and 
laboratory technicians in two health districts of Burkina Faso. 
10.9 Doctors: 30.0, Nurses: 
11.8,  Male: 9.8, 
Female: 12.0 
Moderate 
Pellissier et 
al.[30] 
2012 207 HCWs including medical, nurses, paramedical, cleaning 
and administrative staff in Niamey’s National Hospital, Niger. 
7.2 ND Moderate 
Phillips et 
al.[52]  
2012 473 HCWs including doctors, nurses, mid-wives, lab 
technicians in five Zambian health facilities 
8 ND Moderate 
Shindano et 
al.[34]  
2017 217 HCWs including doctors and nurses in Bukavu, an 
eastern town of the Democratic Republic of Congo 
0.9 ND Moderate 
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Tatsilong et 
al.[53] 
2016 100 HCWs in one health centers in  Mvog-Ada Health Area 9 ND Moderate 
Ziglam et al.[14] 2013 2705 HCWs including doctors, nurses and other paramedical 
staff in a university hospital in Tripoli 
72 ND Moderate 
Ziraba et al.[54] 2010 370 HCWs including doctors, nurses, lab technicians in a 
tertiary hospital, Mulago, Uganda. 
2.2 ND High 
Zoungrana et 
al.[55] 
2014 275 student nurses and midwives working in the medical ward 
of the Bobo-Dioulasso teaching hospital, Burkina Faso. 
11 ND Moderate 
Mbaisi et al.[56] 2013 305 HCWs including doctors, clinical officers, nurses, 
laboratory personnel, mortuary attendants, housekeeping staff 
and clinical students in Rift valley provincial general hospital, 
Kenya. 
42 ND Moderate 
Elduma and 
Saeed[24] 
2011 245 HCWs including doctors, dentists, nurses, laboratory and 
support staff in 3 teaching hospitals in Khartoum 
4.5 Doctors: 30.5, Nurses: 
1.4,  Male: 5.2, Female: 
4.2 
Moderate 
Bett[57] 2014 384 HCWs including doctors, nurses, lab technicians in 
hospitals in Nairobi, Rift Valley and Western provinces 
32 ND High 
Akalu et al.[58] 2016 313 HCWs including doctors and nurses in St Paul Hospital 
Millennium Medical College, Addis Ababa 
1.6 ND Moderate 
aAll studies were of cross-sectional design.
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Figure 2: Meta-analysis for full vaccination coverage among HCWs in Africa 
 
 
 
 
 
 
NOTE: Weights are from random effects analysis
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Table 4. Country estimates of full vaccination coverage among health-care workers  
Country No. of studies Fully-vaccinated HCWs 
(%) 
Botswana 2 39.5 
Burkina Faso 2 10.9 
Cameroon 4 16.9 
Congo DR 1 0.9 
Ethiopia 6 8.7 
Kenya 2 36.9 
Libya 2 62.1 
Niger 1 7.2 
Nigeria 9 39.1 
Rwanda 1 0.8 
South Africa 1 19.9 
Sudan 1 4.5 
Tanzania 1 48.8 
Uganda 1 2.2 
Zambia 1 8.0 
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Figure 3: Meta-analysis for partial vaccination coverage among HCWs in Africa 
NOTE: Weights are from random effects analysis
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Table 5. Subgroup meta-analysis, full vaccination coverage among health-care 
workers in Africa 
Subgroup Fully-vaccinated 
HCWs 
No. studies 
included 
Study 
heterogeneity 
 % (95% CI)  I2 (P-value) 
African region    
West 31.7 (20.3 – 43.0) 12 98.5% (< 0.001) 
Central 13.4 (4.51 – 22.3) 5 97.3% (< 0.001) 
East 15.1 (9.4 – 20.8) 12 98.9% (< 0.001) 
South 26.4 (6.3 – 46.6) 4 99.4% (< 0.001) 
North 62.1 (42.5 – 81.7) 2 98.8% (< 0.001) 
    
Job category    
Doctors 52. 4 (31.1 – 73.8) 5 93.9% (< 0.001) 
Nurses 26.3 (9.7 – 42.9) 6 98.6% (< 0.001) 
    
Sex    
Male 24.2 (9.8 – 38.6) 5 81.7% (< 0.001) 
Female 23.35 (10.4 – 36.2) 5 98.6% (< 0.001) 
    
Type of health-
care facility 
   
Hospital 29.5 (19.2 – 39.9) 25 99.7% (< 0.001) 
Mixeda 9.6 (3.9 – 15.3) 6 97.3% (< 0.001) 
    
Study quality    
High 24.5 (10.1 – 39.0) 5 98.7% (< 0.001) 
Moderate 23.6 (14.8 – 32.3) 27 99.7% (< 0.001) 
Low 34.6 (8.9 – 60.2) 3 98.2% (< 0.001) 
    
Overall 24.7 (17.3 – 32.0) 35 99.6% (< 0.001) 
a Both hospitals and primary care facilities. 
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Figure 4: Common reasons for non-vaccination given by health-care workers 
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